Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

23.75
Delayed Data
As of May 27
 +0.78 / +3.40%
Today’s Change
16.91
Today|||52-Week Range
62.90
-40.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$872.8M

Company Description

Lannett Co., Inc. develops, manufactures, markets and distributes generic versions of pharmaceutical products. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. Lannett was founded in 1942 and is headquartered in Philadelphia, PA.

Contact Information

Lannett Co., Inc.
13200 Townsend Road
Philadelphia Pennsylvania 19154
P:(215) 333-9000
Investor Relations:

Employees

Shareholders

Other institutional42.53%
Individual stakeholders36.21%
Mutual fund holders35.88%

Top Executives

Arthur P. BedrosianChief Executive Officer & Director
Michael J. BogdaPresident & Chief Operating Officer
Martin P. GalvanCFO, Treasurer & Vice President-Finance
Robert EhlingerChief Information Officer & VP-logistics
Mahendra DedhiyaVice President-Scientific Affairs